Search - tctmd.com

Displaying 161 - 180 of 651

Sort: Relevancy | Date

Presentation TCT 2022

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

Presenter: Gordon Wong

September 18, 2022

Presentation TCT 2022

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Presenter: Claudio Cigalini

September 18, 2022

Presentation TCT 2022

Keynote Lecture: Management of Patients with LAA Thrombus (Before or After LAAO Procedures)

Presenter: Sameer Gafoor

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 387: Saftey of Protamine Adminstration After Percutaneous Left Atrial Appendage Occlusion

Presenter: Ahmed El Shaer

September 18, 2022

Presentation TCT 2022

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Presenter: Gauravpal Singh Gill

September 18, 2022

Presentation TCT 2022

TCT 385: Outcomes of Same day Compared to Next day Discharge for Patients Undergoing Left Atrial Appendage Occlusion

Presenter: Riaz Mahmood

September 18, 2022

Presentation TCT 2022

LAAO vs DOACs: Ongoing Trials and My Prediction

Presenter: Chad Rammohan

September 18, 2022

Presentation TCT 2022

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

Presenter: Reda Ibrahim

September 18, 2022

Presentation TCT 2022

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

Presenter: Jennifer Rymer

September 18, 2022

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

TCT 382: Cardiac Computed Tomographic Assessment of Residual Left Atrial Appendage Patency Following Left Atrial Appendage Closure

Presenter: Sung-Han Yoon

September 18, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

Presentation TCT 2022

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

Presenter: Anders Kramer

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

Presentation TCT 2022

Expanding Treatment Population

Presenter: Rahul Sharma

September 17, 2022

Presentation TCT 2022

Optimizing Device Implant

Presenter: Abhijeet Dhoble

September 17, 2022

Presentation TCT 2022

Planning Device Selection

Presenter: Jacqueline Saw

September 17, 2022

Advertisement

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Keynote Lecture: Management of Patients with LAA Thrombus (Before or After LAAO Procedures)

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

TCT 387: Saftey of Protamine Adminstration After Percutaneous Left Atrial Appendage Occlusion

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

TCT 385: Outcomes of Same day Compared to Next day Discharge for Patients Undergoing Left Atrial Appendage Occlusion

LAAO vs DOACs: Ongoing Trials and My Prediction

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Ongoing Clinical Trials and the Future of LAAC

TCT 382: Cardiac Computed Tomographic Assessment of Residual Left Atrial Appendage Patency Following Left Atrial Appendage Closure

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

Recent Clinical Trials & Registries: Update 2022

Expanding Treatment Population

Optimizing Device Implant

Planning Device Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content